Introduction is a strong correlation between GAL4's affinities for TBP and TFIIB measured in vitro and the level of activation Transcriptional activators bind to specific DNA sequences measured in vivo for a series of mutations in the activaand through their activation domains contact the trantion domain of GAL4 (Melcher and Johnston, 1995 ; Wu scriptional machinery. To understand the mechanism of et al., 1996) . The activation domain of the herpes simplex transcriptional activation, it is important to identify the virus activator VP16 also binds to TBP, TFIIB, certain targets of activators in the transcriptional machinery as TAFs, and other components of the transcriptional mawell as the nature of the interactions that lead to gene chinery (Stringer et al., 1990; Ingles et al., 1991; Lin et activation. According to the recruitment model, the actial., 1991; Goodrich et al., 1993; Roberts et al., 1993 ; vator-target interaction recruits the transcriptional ma- Xiao et al., 1994; Zhu et al., 1994; Kobayashi et al., 1995) . chinery to the promoter and thereby activates gene ex-
The yeast transcription initiation machinery includes pression (Ptashne and Gann, 1997) . Interactions between TBP, TFIIA, TFIIB, TFIIE, TFIIF, TFIIH, RNA polymerase the activator and the transcriptional machinery may also II with its 12 subunits, and an SRB/mediator subcomstimulate transcriptional events subsequent to the bindplex. A complex containing all of these components ing of the machinery to the promoter (Ansari et al., 1995;  except TBP and TFIIE has been purified from yeast. This Triezenberg, 1995; Orphanides et al., 1996; Pugh, 1996;  complex, called the RNA polymerase II holoenzyme, Ranish and Hahn, 1996; Hoffmann et al., 1997) .
supplemented with TFIIE and TBP, is capable of reIn prokaryotes, specific interactions between activasponding to activators in a transcription assay pertion domains and the transcriptional machinery have formed in vitro (Koleske and Young, 1994) . Thus, there been identified using a combination of genetic and biomay be a few complexes, possibly just one, that upon chemical methods (Ptashne and Gann, 1997) . For examrecruitment to a promoter lead to high levels of gene ple, a specific interaction between the activation domain expression  Stargell and of CAP (catabolite gene activator protein) and the ␣ Struhl, 1996; Ptashne and Gann, 1997) . Three observasubunit of Escherichia coli RNA polymerase at the lac tions are consistent with the idea that the SRB proteins in the yeast holoenzyme are targets of transcriptional activators. First, the SRB proteins can be purified as ‡ To whom correspondence should be addressed.
SRB2, SRB4, SRB5, and SRB6 Form a Subcomplex
Recombinant SRB2, SRB4, SRB5, and SRB6 proteins were produced using a baculovirus expression system. Interactions between pairs of SRB proteins were studied by incubating an extract containing an influenza hemagglutinin (HA) epitope-tagged SRB protein with an extract containing an equimolar amount of a second, untagged SRB protein. The epitope-tagged SRB was immunopurified, and the eluate was examined by Western blot analysis probing for the untagged protein (Figures 2A-2F ). Pairs of SRB proteins lacking HA epitopes were used tified interactions between SRB2 and SRB5 ( Figure 2A) were assayed for their ability to grow on SC medium containing and between SRB4 and SRB6 ( Figure 2B ), consistent galactose as the sole carbon source. The length of the RNA polymerase II CTD in each strain is diagrammed on the right.
with genetic evidence linking the functions of SRB2 and SRB5 and the functions of SRB4 and SRB6 (Thompson et al., 1993; Thompson and Young, 1995) . The results also indicated that SRB2 and SRB4 interact ( Figure 2C ). a complex separate from RNA polymerase II, and this
In contrast, there were no detectable interactions becomplex, when added back to the purified core RNA tween SRB2 and SRB6 ( Figure 2D ), SRB4 and SRB5 polymerase II and the general transcriptional factors, ( Figure 2E ), or between SRB5 and SRB6 ( Figure 2F ). confers upon them the ability to respond to transcrip- Figure 2G shows that the four SRBs can form a single tional activators in vitro Hengartner et complex in vitro. Extracts containing all four SRB proal., 1995) . Second, the SRB complex binds directly to teins were incubated and immunopurified using antithe activation domain of VP16, a potent viral activator bodies against epitope-tagged SRB4 or SRB6. In both (Hengartner et al., 1995) . Third, the SRB complex intercases, all four SRB proteins were coimmunopurified acts with the carboxy-terminal domain (CTD) of RNA ( Figure 2G , lanes 2 and 3). The interaction studies sugpolymerase II, and the CTD has been implicated in the gest a model for an SRB subcomplex containing all four response to activators in vivo (Scafe et al., 1990 ; Liao proteins as shown in Figure 2H . Gerber et al., 1995) . Gain-of-function mutations in SRB2, SRB4, SRB5, and SRB6 make them attractive candidates for activator targets in the RNA poly-GAL4 Binds to the SRB Subcomplex merase II holoenzyme.
The activation domain of the yeast activator GAL4, We show here, using a combination of biochemical residues 841-875, was expressed fused to glutathione and genetic methods, that the yeast transcriptional acti-S-transferase (GST) and was incubated with the SRB2, vator GAL4 interacts with the SRB4 subunit of the RNA 4, 5, and 6 subcomplex. The GST fusion was affinity polymerase II holoenzyme. purified using glutathione-agarose beads and probed for the presence of SRB proteins by Western blot analysis ( Figure 3A) . The results show that the purified SRB2, Results 4, 5, 6 subcomplex bound to the activation domain (GAL4wt) excised from GAL4. The same GAL4 activation Gene Expression Is Dependent domain with two point mutations (GAL4mut, Val to Glu upon the SRB Proteins at the residue 864 and Leu to Val at the residue 868), Progressive truncation of the CTD of RNA polymerase which is impaired for activation in vivo (Melcher and II causes a corresponding loss in viability of yeast cells Johnston, 1995) , failed to interact with the SRB subgrown in glucose media . As shown complex. in Figure 1 , truncation of the CTD also leads to a loss of viability of yeast cells that utilize galactose as their sole carbon source. We previously showed that RNA GAL4 Binds to SRB4 Three independent approaches were used to identify polymerase mutants bearing only 11 intact CTD repeats are cold sensitive for growth on glucose, and that supthe component of the SRB subcomplex that interacts with the GAL4 activation domain. Affinity chromatograpressing mutations in SRB2, SRB4, SRB5, and SRB6 can restore viability at that temperature (Nonet and Young, phy, label transfer affinity-photo-cross-linking, and surface plasmon resonance all demonstrate that the SRB4 1989; Koleske et al., 1992; Thompson et al., 1993) . These SRB mutations can also suppress the inviability of cersubunit is bound by GAL4. Affinity Chromatography tain CTD truncations when cells are grown on galactose (Figure 1 ). Because galactose utilization requires the GST-GAL4, GST-GAL4 containing activation domain mutations, and GST control protein were loaded sepaactivation of genes under the control of the GAL4 activator, these results raise the possibility that the SRB2, rately on glutathione-agarose columns, and each of the four purified SRB proteins were passed over each of the SRB4, SRB5, and SRB6 proteins play a role in GAL4 responsive activation in vivo.
three columns ( Figure 3B ). Only SRB4 was specifically proteins. An insect cell extract containing one recombinant SRB protein was incubated with another extract containing equimolar amounts of a second recombinant SRB, which lacked (lanes 1 and 3) or contained (lanes 2 and 4) an HA-epitope tag. Insect cell extract containing ␤-galactosidase protein was added to each reaction to serve as a control for specific immunoaffinity. Agarose beads with immobilized 12CA5 anti-HA antibody were added to the reactions, unbound material was removed, and the bound proteins were eluted with HA peptide. Fractions (1/300) of the input (IN; lanes 1 and 2) and 1/40 of the eluate (OUT; lanes 3 and 4) were subjected to SDS-PAGE and analyzed by Western blotting using specific antibodies. The pairs tested were SRB2 and SRB5 (A), SRB4 and SRB6 (B), SRB2 and SRB4 (C), SRB2 and SRB6 (D), SRB4 and SRB5 (E), and SRB5 and SRB6 (F). A schematic interpretation of the binary interactions is presented at the top of each panel.
(G) SRB2, 4, 5, 6 subcomplex. Insect cell extracts containing all four SRB proteins were incubated together and immunoaffinity chromatography was performed as in (A)-(F). In the control reaction containing all four SRB proteins (2ϩ4ϩ5ϩ6; lane 1), no tagged SRB was included. In the other reactions, either SRB4-HA (2ϩ4HAϩ5ϩ6, lane 2) or SRB6-HA (2ϩ4ϩ5ϩ6HA, lane 3) was included. Eluates were subjected to SDS-PAGE and analyzed by Western blotting using specific antibodies.
(H) A model depicting interactions between SRB2, SRB4, SRB5, and SRB6.
retained on the column bearing the wild-type GAL4 actithe label transfer reaction was completed by reducing the disulfide linkage. The label was transferred to SRB4 vation domain. None of the SRB proteins were retained on the column with the mutant activation domain or the ( Figure 4 , lane 2). The experiment does not eliminate the possibility that label was transferred to SRB2 or GST control column. These experiments show that GAL4 interacts directly with SRB4. SRB6 because these proteins are similar in size to the GAL4 derivative, and the background signal produced Label Transfer Affinity Photo-Cross-Linking To confirm that GAL4 interacts with SRB4, we performed by self-labeling of GAL4 obscures the signal in the corresponding size range, but no label was transferred to a photo-cross-linking experiment with the SRB subcomplex and the RNA polymerase II holoenzyme. A radioio-SRB5. The addition of GAL80, a GAL4 inhibitor that binds to the GAL4 activation domain (Ma and Ptashne, 1987) , dinated form of the cross-linker APDP (Chen et al., 1994; Weissman et al., 1994 ) was attached to a GAL4 derivative reduced the amount of label transfer to SRB4 (Figure 4 , lane 3) presumably by competing with SRB4 for binding comprising the DNA-binding domain (residues 1-100) fused to an activation domain (residues 840-881) (Figure to the GAL4 activation domain. The label transfer to SRB4 was also detected in a reaction with RNA polymer-4). This bifunctional cross-linker forms a disulfide bond with a Cys residue in the dark, and when activated by ase II holoenzyme ( Figure 4 , lane 4). This photo-crosslinking result confirms that GAL4 interacts with the SRB ultraviolet (UV) light, the nitrene reactive group at the distal end of the cross-linker will react with any molecule subcomplex by binding to SRB4. Surface Plasmon Resonance (SPR) in its proximity. The cross-linker was reacted in the dark with a GAL4 derivative bearing a Phe to Cys substitution The SPR sensor system can detect interactions between molecules immobilized on a sensor chip and molecules at the residue 856 in its activation domain. The derivatized GAL4 was altered neither in its ability to bind DNA in the solution phase flowing over the chip (Chaiken et al., 1992) . A DNA fragment bearing two GAL4 binding specifically, nor in its ability to activate transcription (A. Z. A. and M. P., unpublished data). The chemically sites was immobilized in one channel on the surface of the sensor chip (as in Wu et al., 1996) . GAL4(1-100ϩ840-modified GAL4 was incubated with the SRB subcomplex, a cross-link was induced by UV irradiation, and 881) and, in a separate experiment, GAL4(1-100) was A GST control (GST) was included. The GST fusions and bound proteins were isolated using glutathione-agarose beads. Fractions (1/10) of the load and all of the pellets were subjected to SDS-PAGE and analyzed by Western blotting using specific antibodies.
(B) SRB4 directly interacts with GAL4. Recombinant SRB2, SRB4, SRB5, or SRB6 proteins were loaded independently onto GSTGAL4wt (lanes 1-4), GST-GAL4mut (lanes 5-8), and GST (lanes 9-12) glutathione-agarose columns. After washing, the columns were eluted with glutathione. Fractions (1/100) of load (L) and the flowthrough (F), and 1/10 of the last wash (W) and the eluate (E) were subjected to SDS-PAGE and analyzed by Western blotting.
bound to the DNA fragment (first injection in Figure 5 ).
SRB4 Gain-of-Function Mutants Compensate for a GAL4 Activation Mutant
The interactions of the GAL4-DNA complex with each of the SRB proteins were studied by flowing sample
Fourteen dominant, gain-of-function SRB4 mutations were previously identified as suppressors of the conproteins over the GAL4-DNA bound chips (second injection in Figure 5 ) and measuring net changes in resonance ditional lethal phenotype of a CTD truncation mutant (Thompson et al., 1993) . We investigated whether any response units (⌬RU). In a parallel channel, the same proteins were passed over a surface that contained nonof these SRB4 mutants could compensate for an activation-defective GAL4 mutant in an otherwise wild-type specific DNA attached to the matrix to measure the nonspecific binding effects and the effects of protein cell. The 14 dominant alleles of the SRB4 gene were introduced (on plasmids) independently into yeast cells buffers on the RU (dotted lines in each sensogram). The results revealed that SRB4 ( Figure 5A ) but not SRB6 containing either the wild-type or the mutant (F869A) GAL4 derivatives. To monitor galactose induction, these ( Figure 5B ) bound to the GAL4-DNA complex containing the activation domain. In agreement with previous recells also contained a ␤-galactosidase reporter gene with five upstream GAL4 binding sites. Two of the musults (Wu et al., 1996) , neither SRB2 nor SRB5 bound to the GAL4 activation domain (data not shown). None tants tested, SRB4-18 and SRB4-20, partially restored galactose activation in the presence of the mutant GAL4 of the four SRB proteins bound to the GAL4 derivative lacking an activation domain ( Figure 5 , right) nor showed activator (data not shown). An identical experiment was carried out in cells in which the chromosomal SRB4 detectable affinity for DNA (data not shown). Therefore, we infer that the increase in RUs in the presence of a gene was replaced with the SRB4-18 and SRB4-20 alleles, with the result that these two alleles substantially functional activation domain in the sensogram in Figure 5A is due to the interaction of the GAL4 activation restored galactose activation in the presence of the mutant GAL4 activator ( Figure 6A ). domain with SRB4. Technical limitations prevent an accurate measurement of the off-rate and consequently SPR analysis revealed that recombinant SRB4-18 and SRB4-20 proteins bound to the mutant GAL4 activation the quantitation of the dissociation constant defining the interactions between the two proteins. However, the domain significantly better than did wild-type SRB4 (Figure 6B ). Neither SRB4 mutant bound detectably to naked estimated dissociation constant for GAL4-TBP interactions is 10 Ϫ7 M, and based on the observation that the DNA. In no case was the binding of the mutant SRB4 to the mutant activator as robust as the binding of their on-rate for GAL4 binding to SRB4 is slower than that for TBP, we estimate that SRB4 binds the GAL4 activation wild-type counterparts with each other. These results demonstrate a correlation between GAL4-SRB4 binding domain with lower affinity than that for TBP.
The experiment of Figure 5D shows that introduction in vitro and the ability of GAL4 to activate transcription in vivo. of a mutation (Phe to Ala at the residue 869) into the GAL4 activation domain, a change that reduces activation in vivo and interaction with TBP in vitro (Wu et al., GAL4 Binding Sites Are Essential Segments of SRB4 1996), abolished binding to SRB4 even when tested at SRB4 concentrations 20-fold above that required to satThe SRB4 gene is essential for yeast cell viability (Thompson et al., 1993) . To obtain clues to the regions urate binding to the wild-type activation domain. Figure  5D also shows that the mutant GAL4 bound GAL80 as of the SRB4 protein that are critical for its function, a series of internal deletion mutations, each affecting 50 efficiently as did wild type, indicating that the activator was not proteolyzed or otherwise damaged during isoamino acids, was constructed in the SRB4 gene and used to replace a wild-type SRB4 gene in yeast cells lation. The SRB4-GAL4 interaction was detected by surface plasmon resoirradiating the samples with UV light. The reaction was terminated nance analysis. In each sensogram, the first change in resonance by addition of DTT, which reduces both the reactive azide and units (⌬RU) is due to binding of a GAL4 derivative (depicted as a the disulfide bond between GAL4 and 125 I-APDP. The 125 I-APDP is circle, DNA-binding domain; and a wave, activation domain) to the transfered and covalently attached to protein bound to the GAL4 immobilized DNA sites (solid line) on the surface of the chip (closed activation domain. Proteins were subjected to SDS-PAGE and larectangle). The net change in RU (⌬RU) after injection of a sample beled proteins were visualized with a phosphorimager. Reactions protein (oval shape) is displayed in the sensogram and attributed were GAL4 alone control (lane 1), GAL4 plus the SRB subcomplex to the binding of the protein to the immobilized GAL4 derivative. (lane 2), GAL4 plus the SRB subcomplex with GAL80 (lane 3), and
The time points at which resonance signals were measured are GAL4 plus RNA polymerase II holoenzyme (lane 4). A control experiindicated (X). The solid trace shows the binding of proteins in a ment with a mutant GAL4 did not show any cross-linking to SRB4. channel containing the cognate GAL4 DNA sites, and the dotted trace shows the profile of the proteins flowing in a channel containing nonspecific DNA of the same length and immobilized at the by plasmid shuffle. The series of SRB4 internal deletion same density as the cognate DNA. Total specific binding is premutations was tested for viability on glucose media at sented as ⌬RU after baseline corrections.
36ЊC ( Figure 7A ). The deletion analysis indicates that two proteins consisting of the wild-type or mutant GAL4
(shaded oval shape) were performed to test binding of the proteins to the GAL4 derivative.
activation domain. Fragments SRB4C and SRB4E bound Figure 5A with (A) Regions of SRB4 required for cell viability. A series of internal purified recombinant SRB4, SRB4-18, and SRB4-20. The ⌬RU valdeletion mutations, each affecting 50 amino acids, was constructed ues for the various SRB4 proteins are presented.
in the SRB4 gene and used to replace a wild-type SRB4 gene in yeast cells by plasmid shuffle. The series of SRB4 internal deletion mutations was tested for viability on glucose media at 36ЊC. (B) Regions of SRB4 that bind to the GAL4 activation domain. Five specifically to the wild-type GAL4 activation domain overlapping SRB4 protein fragments, each FLAG epitope-tagged at ( Figure 7B ). Fragments SRB4A and SRB4B did not bind their N termini, were produced in a baculovirus system and purified.
to the GAL4 activation domain, whereas the SRB4D Each recombinant SRB4 fragment was incubated with GST fusion proteins consisting of the wild-type or mutant GAL4 activation dopolypeptide appeared to bind weakly. Thus, the GAL4 main. The GST fusions and bound proteins were isolated using activation domain appears to have two relatively strong glutathione-agarose beads. Fractions (1/10) of the load and all of binding sites in the SRB4 polypeptide, one in the region the pellets were subjected to SDS-PAGE and analyzed by Western of residues 331-360 and another in the region of resiblotting using anti-FLAG antibody.
dues 561-687. It is striking that these are the regions (C) Point mutations in that are essential for cell viability ( Figure 7A ). If the GAL4 activation domain interacts with these two essential segments of SRB4 protein in vivo, then the Discussion SRB4 mutations that restore activation in vivo by a GAL4 activation domain mutant (Figure 6 ) should affect amino
The multiple lines of genetic and biochemical evidence acid residues in the vicinity of these two segments. Sethat have allowed investigators of prokaryotic transcripquence analysis of SRB4-18 and SRB4-20 alleles retion activation to identify physiologically relevant activavealed that this is indeed the case ( Figure 7C ). Thus, tor targets are not as well established for eukaryotic the segments of SRB4 that are bound by the GAL4 activators. We have attempted to provide the combinaactivation domain in vitro contain the suppressing mutation of genetic and biochemical evidence necessary to tions that restore activation by a GAL4 activation domain identify a physiologically relevant target for a yeast transcriptional activator. Genetic studies have implicated mutant in vivo.
the CTD, and the associated SRB/mediator complex, should improve our understanding of gene activation in higher eukaryotes. in the process of transcription activation (Allison and Ingles, 1989; Nonet and Young, 1989; Scafe et al., 1990; Liao et al., 1991; Gerber et al., 1995; Myers et al., 1998;  GAL4 Interacts with Multiple Components reviewed in . Biochemical of the Transcriptional Machinery studies have demonstrated that reconstitution of actiSeveral investigators have proposed that TBP and the vated transcription by RNA polymerase II in a yeast RNA polymerase II holoenzyme can be recruited indesystem requires the SRB/mediator complex (Kim et al., pendently to promoters, in part because holoenzymes 1994; Hengartner et al., 1995) . RNA polymerase II holopurified thus far from yeast lack TBP (Koleske and enzymes containing the SRB/mediator complex are reYoung, 1995; Stargell and Struhl, 1996; Struhl, 1996) . sponsive to activators in vitro, whereas RNA polymerase
The ability of the GAL4 activation domain to interact II and general transcription factors alone are not (Kim with TBP (Melcher and Johnston, 1995; Wu et al., 1996 Wu et al., ) et al., 1994 Koleske and Young, 1994; and SRB4 therefore suggests how GAL4 may recruit the al., 1995). This genetic and biochemical evidence makes entire transcription apparatus to promoters. GAL4 could the SRB/mediator complex an attractive candidate for act by recruiting TBP and then the holoenzyme to a a target of transcriptional activators, but prior to this promoter. However, at the GAL1-10 promoter, GAL4 study a specific target protein had not been identified.
has multiple binding sites, and multiple GAL4 proteins We provide here five lines of evidence for the identifiassociated with this promoter could bind to TBP and cation of SRB4 as a specific target of the activation the holoenzyme independently and without a requiredomain of GAL4. First, affinity chromatography experiment for a particular order of assembly. ments with individual SRB proteins show that GAL4
It seems likely that multiple activator-target interacbinds to SRB4 only when the activator contains a functions play a synergistic role in eliciting high levels of gene tional activation domain. Second, photo-cross-linking expression in vivo. In prokaryotes, catabolite activator studies confirm that SRB4, when part of the holoenzyme protein (CAP) interacting with two different components or an SRB subcomplex, becomes closely associated of E. coli RNA polymerase elicits a much higher level with the activation domain of GAL4. Third, SPR experiof activation than either single interaction does alone ments demonstrate that the activation domain of GAL4 (Busby et al., 1994) . Furthermore, multiple interactions binds to SRB4, but not to the other three SRBs, even by a single activator may affect different steps in activaat submillimolar concentrations. Fourth, mutations have tion. Bacterial CAP, for example, interacts with two difbeen identified in SRB4 that restore transcription elicited ferent regions of the ␣ subunit of E. coli RNA polymerase, by a weakened GAL4 activator in vivo; unlike the wildand each interaction is responsible for a specific mechatype SRB4 protein, SRB proteins containing the comnistic consequence (e.g., formation of closed complex pensatory mutations bind to the weakened GAL4 activaand isomerization of closed complex to open complex) tion domain in vitro. And finally, we have found that the (Niu et al., 1996) . GAL4 activation domain interacts with the portions of SRB4 in which the compensatory mutations occur.
SRB4 joins a substantial list of proposed targets for SRB/Mediator Complex Is a Likely Target activators. The most thoroughly studied activator, VP16, for Multiple Transcriptional Regulators has been shown to bind to TBP, TAFIIs, TFIIB, TFIIF, Although the precise subunit composition of the SRB/ TFIIH, and TFIIA (Stringer et al., 1990; Ingles et al., 1991;  mediator complex is not yet resolved, the components Lin et al., 1991; Goodrich et al., 1993; Roberts et al., that have been identified thus far indicate that this com-1993; Xiao et al., 1994; Zhu et al., 1994; Kobayashi et plex is involved in many important regulatory processes al., 1995). While it is possible that VP16 does interact in yeast cells. In addition to the nine SRB proteins, with all these factors during activation, it is not yet clear GAL11, SIN4, RGR1, ROX3, and seven MED proteins that the binding observed with the isolated general tranhave been identified as components of this complex scription factors also occurs when these factors are and of the holoenzyme ; Koleske and components of a holoenzyme. Furthermore, the ability Young, 1994; Barberis et al., 1995; Hengartner et al., to bind to most of these factors is not sufficient for 1995; Li et al., 1995; Liao et al., 1995;  Gustafsson et al., activation, since transcription systems reconstituted 1997; Lee et al., 1997; Myers et al., 1998) . Genes required with highly purified TBP, TFIIB, TFIIF, TFIIH, TFIIE, TFIIA, for glucose regulation (Kuchin et al., 1995; Song et al., and Pol II are not activated by VP16 (reviewed in Or-1996) , repression of early meiotic-specific genes during phanides et al., 1996; Hoffmann et al., 1997) . The addimitotic growth (Strich et al., 1989) , and repression of tion of TAFIIs to some purified systems can reconsitute a-specific genes (Wahi and Johnson, 1995) have been activation (reviewed in Burley and Roeder, 1996; Ver- identified as SRB genes. GAL11 is required for full activrijzer and , but genetic studies reveal that ity at many promoters, including those encoding en-TAF II s are not essential for expression of all genes in zymes metabolizing galactose (Suzuki et al., 1988) . SIN4, yeast and mammalian cells (Wang and Tjian, 1994;  RGR1, and ROX3 have been implicated in both positive Apone et al., 1996; Moqtaderi et al., 1996; Walker et and negative transcriptional regulation at a variety of al., 1996) . Further characterization of mammalian SRB/ genes (Jiang and Stillman, 1992) . All these observations mediator-containing complexes (Ossipow et al., 1995;  suggest that the SRB/mediator complex is a target of Chao et al., 1996; Maldonado et al., 1996; Pan et al., many transcriptional regulators. Precise identification 1997; Scully et al., 1997) and other complexes that confer activation (Burley and Roeder, 1996 ; Verrijzer and of the targets of such regulators in the SRB/mediator between SRB subunits. Monoclonal antibody 12CA5 was coupled to protein A-agarose, and an insect cell extract containing HA-tagged recombinant SRB (10-15 g) was incubated with a second extract Experimental Procedures containing an equimolar amount of untagged recombinant SRB for 3 hr on ice. The 12CA5 coupled agarose beads (100 l), equilibrated Genetic Analysis in MTB (Hengartner et al., 1995) , were added to the reactions and Yeast strains used in this study are listed in Table 1 . Yeast medium incubated for 3 hr at 4ЊC with constant agitation and washed extenwas prepared as described (Thompson et al., 1993) . Yeast transforsively with MTB, and bound proteins were eluted with 100 l of 1 mations were done using a lithium acetate procedure (Gietz et al., mg/ml HA peptide. 1992) . Plasmid shuffle techniques were performed as described Interactions between SRB proteins and the GAL4 activation do- (Boeke et al., 1987) . main were tested by affinity chromatography and GST pull-down The growth phenotypes of cells containing CTD truncations and experiments. GST affinity columns were prepared by immobilizing dominant suppressing alleles were assayed by plasmid shuffle with GST-GAL4 activation domain fusion proteins on glutathione-agarose beads as described (Smith and Johnson, 1988) . The columns strains Z555, Z556, Z557, Z777, and Z812. Plasmids containing varicontained 200 l matrix and 300 g of GST fusion proteins. Purified ous CTD truncations have been described .
recombinant SRB proteins (approximately 10 g) were loaded onto Selection of dominant SRB4 alleles that alleviate decreased galacthe columns, and proteins interacting with GST fusions were eluted tose inducibility by mutant GAL4 was done with strain Z815. Z815 as described (Hengartner et al., 1995) . harboring either wild-type (pRJR182) or mutant (pRJR329) GAL4
GST pull-down experiments were performed with the SRB subderivatives (Wu et al., 1996) were transformed with LEU2 CEN plascomplex. The SRB subcomplex (5 g) was incubated with 20 g of mids containing dominant SRB4 alleles. The transformants were GST-GAL4 fusion proteins for 3 hr on ice. Glutathione-agarose assayed for ␤-galactosidase activity as described (Scafe et al., beads (20 l) were added and incubated for 1 hr at 4ЊC with constant 1990). Strains Z859, Z860, and Z861, which have a chromosomal agitation. Beads were spun down, washed extensively with MTB, SRB4 deletion covered by SRB4, and proteins eluted by boiling in 20 l of sample buffer. CEN plasmids, respectively, were generated by transforming a PCR fragment bearing TRP1 gene flanked by SRB4 sequences. WildPhoto-Cross-Linking type or mutant GAL4 was transformed into these strains indepen-A GAL4 derivative, GAL4 (1-100ϩ840-881) with a Phe to Cys subdently and assayed for ␤-galactosidase activity as above.
stitution at the residue 856, was purified and reduced with 10 mM Plasmids containing SRB4 deletion mutations were transformed DTT for 1 hr in buffer A (20 mM HEPES [pH 8.2], 150 mM NaCl, 0.1 into the strain Z572 and grown on SC medium containing 5-FOA at mM EDTA, 20 M ZnSO4). Excess DTT was removed by using a 36ЊC.
gel filtration spin column (Pierce) equilibrated in buffer A. The reduced protein was incubated for 90 min at room temperature with 125 I-APDP (N-[4-(p-azidosalicylamido)butyl]-3Ј[2Ј-pyridyldithio]propioRecombinant Proteins namide). APDP (Pierce) was labeled with NaI 125 as suggested by the Recombinant SRB2 and SRB5 proteins were purified from bacteria manufacturer. Unreacted 125 I-APDP was also removed with a gel as described (Koleske et al., 1992; Thompson et al., 1993) . Recombifiltration spin column equilibrated in MTB. The radiolabeled GAL4 nant FLAG-SRB proteins were expressed in Sf21 cells and purified derivative protein (0.27 M) was incubated, in the dark, with the using a FLAG M2 immunoaffinity column (Kodak) as described (Koh SRB subcomplex or RNA polymerase II holoenzyme (0.34 M) in 30 et al., 1997) . For purification of the subcomplex containing SRB2, l of MTB on ice for 1 hr. For competition experiments, GAL80 was SRB4, SRB5, and SRB6, Sf21 cells (10 9 cells) were coinfected with added to the reaction at the final concentration of 1 M. Photoviruses expressing SRB2, FLAG-SRB4, SRB5, and SRB6 at an moi cross-linking was initiated with long-range UV (320 nm) for 5 min. of 3-5 for each virus. Cells were collected 60 hr postinfection. The
The reaction was stopped and quenched with 20 mM DTT. The cell extract (30 ml) was purified using the FLAG M2 immunoaffinity proteins were then denatured in sample buffer and subjected to a column and a Mono Q 5/5 column (Pharmacia). GST fusions of 4%-20% Tricine-SDS-PAGE. Radiolabeled proteins were visualized GAL4 activation domains (GST-34 and mutant 12) were purified using Fuji BAS2000 phosphorimager. as described (Smith and Johnson, 1988) . GAL4 derivatives were expressed in the bacterial strain BL21(DE3) pLysS and purified on Surface Plasmon Resonance (SPR) Analysis an SP-Sepharose column (Pharmacia) (Wu et al., 1996) and a SuperSensor chips with an immobilized double-stranded DNA carrying two consensus GAL4 binding sites were prepared as described dex G-75 column (Pharmacia). (Wu et al., 1996) . Protein-protein interactions were measured using Goodrich, J.A., Hoey, T., Thut, C.J., Admon, A., and Tjian, R. (1993) . Drosophila TAFII40 interacts with both a VP16 activation domain BIAcore 2000 (Pharmacia) in the buffer MTB at 25ЊC at a flow rate of 15 l/min. Typically 120 l of 40 nM GAL4 derivative was passed and the basal transcriptional factor TFIIB. Cell 75, 519-530. over the immobilized DNA, which resulted in saturated binding to the Gustafsson, C.M., Myers, L.C., Li, Y., Redd, M.J., Lui, M., Erdjument-DNA-binding sites and gave the first increase in resonance response Bromage, H., Tempst, P., and Kornberg, R.D. (1997) . Identification units (RU). Interactions between this GAL4-DNA complex and other of Rox3 as a component of mediator and RNA polymerase II holoenproteins were determined by flowing 120 l of 50 nM solution of a zyme. J. Biol. Chem. 272, 48-50. sample protein over the preformed GAL4-DNA complex. Control Hengartner, C.J., Thompson, C.M., Zhang, J., Chao, D.M., Liao, experiments with nonspecific DNA and with immobilized streptavi-S.-M., Koleske, A.J., Okamura, S., and Young, R.A. (1995) . Associadin alone were simultaneously conducted to determine the backtion of an activator with an RNA polymerase II holoenzyme. Genes ground level of surface binding of proteins and the increase in RUs Dev. 9, 897-910. due to the difference in the refractive index of the protein storage Hoffmann, A., Oelgeschlä ger, T., and Roeder, R.G. (1997) . Considbuffer.
erations of transcriptional control mechanism: do TFIID-core promoter complexes recapitulate nucleosome-like functions? Proc.
